
IRB Compliance Documentation & Risk Manager
Document deviations, assess regulatory risk, and prepare IRB audit evidence
What You Can Do
Systematically categorize protocol deviations, evaluate their regulatory risk using evidence-based matrices, and compile comprehensive audit documentation that satisfies IRB and regulatory inspections. You'll generate detailed deviation logs with severity assessments, corrective action plans, and compliance narratives that demonstrate institutional oversight and quality assurance.
Features
Capture protocol deviations with standardized templates including deviation type, date, population affected, immediate actions taken, and root cause analysis to create complete audit trails.
Automatically assess deviation risk using multi-factor matrices (impact, detectability, scope) to classify deviations as minor, moderate, or major for appropriate escalation.
Cross-reference deviations against 21 CFR Part 11, ICH-GCP, and FDA regulations to identify which requirements were affected and generate compliance narratives.
Compile deviation logs, risk assessments, corrective actions, and compliance documentation into organized evidence packages ready for IRB, FDA, or auditor review.
Generate systematic corrective and preventive action (CAPA) plans with timelines, responsible parties, and verification steps to address root causes and prevent recurrence.
Create visual timeline summaries of deviations chronologically and identify patterns (clustering by site, protocol section, or phase) to detect systemic issues.
Draft professional summaries for regulatory submissions explaining deviations in context, mitigation strategies, and lessons learned using agency-appropriate language.
Example Output
Example 1: Deviation Log Entry
Deviation ID: DEV-2024-043
Date Identified: 2024-07-15
Protocol Section: 5.2.1 (Informed Consent)
Type: Procedural - Consent timing deviation
Severity: Moderate
Description: One subject enrolled prior to obtaining written informed consent; consent obtained retroactively within 24 hours with documented justification.
RegulatoryImpact: Potential 21 CFR 312.3(b) concern; mitigation documented
CAPA Status: In Progress - Retraining completed 2024-07-20
Example 2: Risk Assessment Matrix
Deviation Category | Frequency | Detectability | Scope | Risk Level | Action
--- | --- | --- | --- | --- | ---
Inclusion/Exclusion Error | Low | High | Single Subject | MINOR | Document + Monitor
Dose Deviation >20% | Medium | Medium | Multiple Subjects | MAJOR | Halt Enrollment + CAP
Missing Safety Lab | Low | High | Single Subject | MODERATE | Retroactive Review + CAP
Example 3: IRB Submission Summary
During this trial period, 12 deviations were identified and managed: 8 minor procedural deviations (administrative), 3 moderate protocol variances (dose administration timing), and 1 major protocol deviation (consent deficiency). All deviations were reported to the IRB within required timelines. Root cause analysis identified insufficient site staff training. Comprehensive retraining was implemented 2024-07-20 and compliance monitoring shows 100% adherence post-intervention over 30 days.
What's Included
- Deviation Classification Framework: Templates and decision trees to categorize deviations by type (procedural, safety, data integrity) and severity level with standardized terminology.
- Regulatory Risk Matrix: Multi-dimensional assessment tools mapping deviations against FDA regulations (21 CFR 312, 211, 11) and ICH-GCP requirements to flag regulatory implications.
- Corrective Action Plan Template: Structured CAPA framework with root cause analysis, corrective actions, preventive measures, timeline, accountability, and verification milestones.
- Audit Evidence Checklist: Comprehensive checklist ensuring all required documentation is present, organized, and IRB/auditor-ready for inspections and submissions.
- Regulatory Submission Language Guide: Pre-written narratives and regulatory-compliant language for explaining deviations to IRBs and agencies with appropriate risk context and mitigation framing.
Who It's For
- Research Coordinators
- Compliance Officers
- Clinical Trial Managers
- IRB Directors
- Regulatory Affairs Specialists
Best For
- Protocol Deviation Documentation
- IRB Audit Preparation
- Regulatory Risk Assessment
- FDA Inspection Response
- CAPA Development






